Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.

OBJECTIVE: To evaluate treatment practices for uncomplicated malaria after the policy change from chloroquine to sulfadoxine-pyrimethamine and to artemether-lumefantrine in Zambia. DESIGN: Cross sectional survey. SETTING: Outpatient departments of all government and mission facilities in four distr...

Bibliografske podrobnosti
Main Authors:	Zurovac, D, Ndhlovu, M, Rowe, A, Hamer, D, Thea, D, Snow, R
Format:	Journal article
Jezik:	English
Izdano:	2005

Podobne knjige/članki

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
od: Zurovac, D, et al.
Izdano: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
od: Zurovac, D, et al.
Izdano: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
od: Chanda Pascalina, et al.
Izdano: (2007-03-01)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
od: Sipilanyambe, N, et al.
Izdano: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
od: Sipilanyambe, N, et al.
Izdano: (2008)

Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
od: Zurovac, D, et al.
Izdano: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
od: Snow Robert W, et al.
Izdano: (2008-01-01)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
od: Zurovac, D, et al.
Izdano: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
od: Zurovac, D, et al.
Izdano: (2008)

A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
od: Hawela Moonga, et al.
Izdano: (2007-02-01)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
od: Ssekitooleko James, et al.
Izdano: (2008-09-01)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.
od: Sudoi, R, et al.
Izdano: (2012)

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia
od: Manyando Christine, et al.
Izdano: (2010-09-01)

Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial.
od: Skarbinski, J, et al.
Izdano: (2009)

Introduction of malaria rapid diagnostic tests, new guidelines, and artemether-lumefantrine in Kenya: A cluster randomized trial
od: Skarbinski, J, et al.
Izdano: (2007)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
od: Wasunna, B, et al.
Izdano: (2008)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
od: Wasunna, B, et al.
Izdano: (2008)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
od: Tchaparian, E, et al.
Izdano: (2016)

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
od: van Vugt, M, et al.
Izdano: (2000)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya
od: Sudoi Raymond K, et al.
Izdano: (2012-02-01)

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
od: Dev Vas, et al.
Izdano: (2009-05-01)

Improved diagnostic testing and malaria treatment practices in Zambia.
od: Hamer, D, et al.
Izdano: (2007)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
od: Mcgready, R, et al.
Izdano: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
od: McGready, R, et al.
Izdano: (2009)

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis
od: Rita Patrocínio-Jesus, et al.
Izdano: (2019-01-01)

The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
od: Quique Bassat
Izdano: (2011-12-01)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
od: Denis, M, et al.
Izdano: (2006)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
od: Tarning, J, et al.
Izdano: (2009)

Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane<sup>®</sup>) for the treatment of uncomplicated <it>Plasmodium falciparum </it>in children in Zambia
od: Kango Mabvuto, et al.
Izdano: (2006-08-01)

Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine
od: Gavin G. Rutledge, et al.
Izdano: (2017-08-01)

Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine
od: Tijs K. Tournoy, et al.
Izdano: (2022-06-01)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
od: Zurovac Dejan, et al.
Izdano: (2008-02-01)

Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria
od: Chotsiri, P, et al.
Izdano: (2019)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
od: Sileshi Belew, et al.
Izdano: (2020-04-01)

Genomic characterization of recrudescent plasmodium malariae after treatment with artemether/lumefantrine
od: Rutledge, G, et al.
Izdano: (2017)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
od: Tarning, J, et al.
Izdano: (2022)

Effects of nanocapsules containing lumefantrine and artemether in an experimental model of cerebral malaria
od: Bianca Portugal Tavares de Moraes, et al.
Izdano: (2024-11-01)

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
od: Gbadoé Adama, et al.
Izdano: (2010-01-01)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
od: Joel Tarning, et al.
Izdano: (2022-10-01)

Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial
od: Krause Eike, et al.
Izdano: (2008-09-01)